AE Wealth Management’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-508
Closed -$20.4K 1546
2023
Q4
$20.4K Buy
508
+8
+2% +$212 ﹤0.01% 2013
2023
Q3
$8.1K Buy
500
+167
+50% +$5.25K ﹤0.01% 1925
2023
Q2
$11.6K Buy
+333
New +$11.9K ﹤0.01% 1878

Other funds holding ICCM

AE Wealth Management's ICCM Position: Q1 2024 in Review

AE Wealth Management sold out of IceCure Medical (ICCM) in Q1 2024, closing a stake of 508 shares — an estimated $20.4K sold.

AE Wealth Management first reported a position in ICCM in Q2 2023 and held it in 3 quarters. The position peaked at $20.4K in Q4 2023. 12 funds tracked by Wall St. Rank hold ICCM as of Q1 2024.

  • AE Wealth Management reported no remaining IceCure Medical position as of Q1 2024 after selling out during the quarter.
  • AE Wealth Management sold 508 IceCure Medical shares in Q1 2024, an estimated $20.4K.
  • AE Wealth Management first reported a position in IceCure Medical in Q2 2023 and held it in 3 quarters.
  • AE Wealth Management's IceCure Medical position peaked at $20.4K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2024.

Based on AE Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.